Reta
A next-generation triple agonist targeting GLP-1, GIP, and glucagon pathways. Studied in laboratory models for metabolic signaling and energy regulation.
Intended Use:• For laboratory research purposes only.• Not intended for human or veterinary use, including medical, therapeutic, or diagnostic applications.
Compliance Notice:This product is sold strictly for research purposes and is not approved for use in humans or animals. Any misuse or off-label application is strictly prohibited.
By purchasing this product, the buyer represents that it will be used strictly for research purposes in a qualified laboratory setting.
All orders are processed through our fulfillment facility and require 2–9 business days for handling prior to shipment. Tracking details are issued once the order has been dispatched. Delivery timelines are carrier estimates and are not guaranteed.
